tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Seedhouse, 264 are a BUY (94.29%), 14 are a HOLD (5%), 2 are a SELL (0.71%).
Analyst Steven Seedhouse, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 42.58% that have a potential upside of 67.89% achieved within 356 days. Previously, Steven Seedhouse worked at RAYMOND JAMES.
Steven Seedhouse’s has documented 495 price targets and ratings displayed on 33 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on APLS, Apellis Pharmaceuticals at 09-May-2025.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS) at 6/29/2021. The price target of $168 was fulfilled within 2 days with a profit of $16.39 (10.81%) receiving and performance score of 54.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$205
$22.5 (12.33%)
4 years 8 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold
$173
$-9.5 (-5.21%)
$156
4 years 10 days ago
(03-May-2021)
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
$190
4 years 17 days ago
(26-Apr-2021)
9/11 (81.82%)
$34.41 (22.12%)
350
Hold
$166
$-16.5 (-9.04%)
$175
4 years 3 months 9 days ago
(03-Feb-2021)
23/23 (100%)
$10.41 (6.69%)
828
Buy
$155
4 years 4 months 6 days ago
(06-Jan-2021)
7/7 (100%)
$36.79 (31.12%)
395
Which stock is Steven Seedhouse is most bullish on?
Which stock is Steven Seedhouse is most reserved on?
What Year was the first public recommendation made by Steven Seedhouse?
